4.8 Article

Robust ERα-Targeted Near-Infrared Fluorescence Probe for Selective Hydrazine Imaging in Breast Cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Chemistry, Medicinal

Activable Targeted Protein Degradation Platform Based on Light-triggered Singlet Oxygen

Silong Zhang et al.

Summary: This study presents a targeted protein degradation platform that utilizes the conjugation of photosensitizers and protein ligands. The platform enables the degradation of target proteins through light-triggered reactions, with high spatiotemporal precision and excellent anti-proliferation effects. The research results establish a modular strategy for controllable protein degradation.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Multidisciplinary

An Activatable Polymeric Nanoprobe for Fluorescence and Photoacoustic Imaging of Tumor-Associated Neutrophils in Cancer Immunotherapy

Yan Zhang et al.

Summary: This study presents an activatable semiconducting polymer nanoprobe for imaging tumor-associated neutrophils using near-infrared fluorescence and photoacoustic imaging. The nanoprobe reacts with neutrophil elastase to enhance imaging signals and correlate with the intratumoral population of TANs.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)

Article Chemistry, Multidisciplinary

A Dual-Locked Activatable Phototheranostic Probe for Biomarker-Regulated Photodynamic and Photothermal Cancer Therapy

Xin Wei et al.

Summary: This study reports a dual-locked activatable phototheranostic probe that can activate fluorescence signals and switch between photodynamic therapy and photothermal therapy for precise cancer treatment.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

18F-FES PET/CT for Characterization of Brain and Leptomeningeal Metastasis in Double Primary Cancer Patient

Yeongjoo Lee et al.

CLINICAL NUCLEAR MEDICINE (2022)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Discrepancy between [18F]-FES and [18F]-FDG PET/CT in ER-positive breast cancer with oesophageal metastasis

Peerapon Kiatkittikul et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)

Article Chemistry, Medicinal

Discovery of Thieno[2,3-e]indazole Derivatives as Novel Oral Selective Estrogen Receptor Degraders with Highly Improved Antitumor Effect and Favorable Druggability

Zhengyu Lu et al.

Summary: This study describes the structure-based optimization of LSZ102, resulting in the identification of compound 40 as a preferred candidate for endocrine therapy of estrogen receptor positive breast cancer. Compound 40 showed superior pharmacological profiles, including growth inhibition of cancer cells and strong antitumor efficacy in a mouse model.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Discovery of Novel Bicyclic Phenylselenyl-Containing Hybrids: An Orally Bioavailable, Potential, and Multiacting Class of Estrogen Receptor Modulators against Endocrine-Resistant Breast Cancer

Xiangping Deng et al.

Summary: This study identified a new ER modulator, 34b, which showed antiproliferative effects against breast cancer cells and induced apoptosis through mitochondrial dysfunction. In vivo experiments demonstrated that 34b had better tumor suppression than tamoxifen. Therefore, this compound has potential as a candidate for treating breast cancer, particularly tamoxifen-resistant breast cancer.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Multidisciplinary Sciences

Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer

Shenghong Ma et al.

Summary: This study reveals the involvement of Hippo signalling in the transcriptional repression of ESR1 and its impact on ER+ breast cancer. The inhibition of LATS can effectively repress ESR1 expression and inhibit the growth of ER+ breast cancer cells. The findings highlight LATS as a potential therapeutic target for endocrine-resistant breast cancers.

NATURE COMMUNICATIONS (2022)

Article Environmental Sciences

Design of a ratiometric near-infrared fluorescent probe with double excitation for hydrazine detection in vitro and in vivo

Tengteng Zhang et al.

Summary: A new near-infrared ratiometric fluorescent probe (Ac-HY) was designed for rapid and sensitive detection of hydrazine. The probe exhibited high selectivity and sensitivity, making it suitable for various applications in environmental sciences and biological systems.

SCIENCE OF THE TOTAL ENVIRONMENT (2022)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Biochemistry & Molecular Biology

ERα is an RNA-binding protein sustaining tumor cell survival and drug resistance

Yichen Xu et al.

Summary: ERα plays a crucial role in breast cancer as a non-canonical RNA-binding protein, separate from its DNA-binding activity. Through controlling different steps of RNA metabolism, ERα mediates alternative splicing of XBP1 and translation of eIF4G2 and MCL1 mRNA, facilitating cell survival under stress conditions and maintaining tamoxifen resistance.
Review Oncology

Therapeutic targeting of the hypoxic tumour microenvironment

Dean C. Singleton et al.

Summary: The article discusses the relationship between two different tumor microenvironment research fields: physicochemical gradients and cellular interactions, with a focus on translational therapeutic opportunities. Hypoxia is a common feature of tumors, influencing various cancer characteristics and responses to anticancer therapies.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Review Nanoscience & Nanotechnology

Molecular imaging and disease theranostics with renal-clearable optical agents

Penghui Cheng et al.

Summary: Renal-clearable optical agents (RCOAs) are rapidly excreted from the body via the kidneys, making them suitable for targeted kidney imaging and early kidney injury detection, as well as deep tumor penetration and high-contrast tumor imaging.

NATURE REVIEWS MATERIALS (2021)

Article Medicine, Research & Experimental

Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma

Binita Chakraborty et al.

Summary: Research has shown that estrogen signaling through the estrogen receptor plays a significant role in melanoma growth by affecting intratumoral macrophage function, CD8+ T cell activity, and ICB resistance. Targeting estrogen signaling within myeloid cells could potentially reverse immune suppression and enhance the efficacy of ICB in melanoma patients.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Spectroscopy

Phenothiazine-based fluorescence probe for ratiometric imaging of hydrazine in living cells with remarkable Stokes shift

Xiao-Yang Qiu et al.

SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2020)

Review Chemistry, Inorganic & Nuclear

Fluorescent sensors for the detection of hydrazine in environmental and biological systems: Recent advances and future prospects

Xiang-Yang Zhang et al.

COORDINATION CHEMISTRY REVIEWS (2020)

Article Spectroscopy

A colorimetric and near-infrared ratiometric fluorescent probe for hydrazine detection and bioimaging

Cuiyan Wu et al.

SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2020)

Review Medicine, General & Internal

Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer

Harold J. Burstein

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Oncology

Breast cancer statistics, 2019

Carol E. DeSantis et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2019)

Article Toxicology

The Isoniazid Metabolites Hydrazine and Pyridoxal Isonicotinoyl Hydrazone Modulate Heme Biosynthesis

Christopher Trent Brewer et al.

TOXICOLOGICAL SCIENCES (2019)

Article Chemistry, Multidisciplinary

Hydrazine Expos: The Next-Generation Fluorescent Probe

Yuna Jung et al.

ACS SENSORS (2019)

Article Medicine, Research & Experimental

A Novel Estrogen Receptor α-Targeted Near-Infrared Fluorescent Probe for in Vivo Detection of Breast Tumor

Chu Tang et al.

MOLECULAR PHARMACEUTICS (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer

Amy M. Fowler et al.

JOURNAL OF NUCLEAR MEDICINE (2016)

Article Chemistry, Organic

Hydrazine-Selective Chromogenic and Fluorogenic Probe Based on Levulinated Coumarin

Myung Gil Choi et al.

ORGANIC LETTERS (2011)